Discovery and development of antitumor drugs focused on the molecular clock of dedifferentiation and apoptosis during carcinogenesis
Project/Area Number |
21390047
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Kyushu University |
Principal Investigator |
OHDO Shigehiro 九州大学, 大学院・薬学研究院, 教授 (00223884)
|
Co-Investigator(Kenkyū-buntansha) |
KOYANAGI Satoru 九州大学, 大学院・薬学研究院, 准教授 (60330932)
NAOYA Matsunaga 九州大学, 大学院・薬学研究院, 助教 (10432915)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥18,330,000 (Direct Cost: ¥14,100,000、Indirect Cost: ¥4,230,000)
Fiscal Year 2011: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2010: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2009: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Keywords | 体内時計 / がん / 分化 / アポトーシス / 創薬 |
Research Abstract |
Circadian clock systems have been related in cell cycle and carcinogenesis. Theexpression of molecular clock genes is altered in cancer patients. However, the influenceof an alteration of molecular clock works during carcinogenesis has not been investigatedyet. In this study, the hepatocarcinogenesis by diethylnitrosoamine(DEN) in mice wasinhibited by the down-regulation of cellular dedifferentiation related genes expression. These findings suggest that the control of cellular dedifferentiation related genesexpression is important in carcinogenesis.
|
Report
(4 results)
Research Products
(26 results)